Results from the aformentioned study about the role of metabolic reprogramming in SSc pathogenesis (59), demonstrated that TGF‐β1 is able to enhance succinate production, which determines an increase of collagen expression, thus providing a link between the pro-fibrotic milieu of the disease and the metabolic activation of the inflammasome. Here, TGFB1 is linked to systemic sclerosis.